how are glp-1 drugs made Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 Receptor Agonist Services for
Description
Agca, R
Weight regain after stopping treatment may affect the long-term sustainability of the observed benefits
10.1007/s40265-023-01932-2 66
Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
Exendin-4 relieves the inhibitory effects of high glucose on the proliferation and osteoblastic differentiation of periodontal ligament stem cells
